Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
(NasdaqGM:STIM), MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial […]